MiSight 1 DAY

Currently unavailable

MiSight 1 day - the first soft contact lenses proven to slow the progression of short-sightedness (myopia) in children.
MiSight 1 day is FDA-approved for slowing the progression of myopia (nearsightedness or short-sightedness) in children, who at initiation of treatment are 8-12 years of age.

According to a study published in Clinical Ophthalmology in August 2018, 41.9% of U.S. children ages 5-19 are myopic. This is due in part to changing lifestyles, with children spending less time outdoors and more time spent focusing on close objects such as digital screens.